These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10397611)

  • 1. Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in rats.
    Bethune C; Blum A; Geyer JR; Silber JR; Ho RJ
    Pharm Res; 1999 Jun; 16(6):896-903. PubMed ID: 10397611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats.
    Bethune CR; Geyer RJ; Spence AM; Ho RJ
    Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of lipid association on lomustine (CCNU) administered intracerebrally to syngeneic 36B-10 rat brain tumors.
    Yimam MA; Bui T; Ho RJ
    Cancer Lett; 2006 Dec; 244(2):211-9. PubMed ID: 16455196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spin labeled antioxidants protect bacteria against the toxicity of alkylating antitumor drug CCNU.
    Gadjeva V; Lazarova G; Zheleva A
    Toxicol Lett; 2003 Oct; 144(3):289-94. PubMed ID: 12927347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization of nitrosourea-resistant Mer+ human tumor cells to N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea by mild (41 degrees C) hyperthermia.
    Mulcahy RT; Gipp JJ; Tanner MA
    Cancer Res; 1988 Mar; 48(5):1086-90. PubMed ID: 3342391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
    Russo RG; Cattaneo MT; Bartosek I
    Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of RNA synthesis in murine ependymoblastoma by the combination of amphotericin B and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Laurent G; Dewerie-Vanhouche J; Machin D; Hildebrand J
    Cancer Res; 1980 Mar; 40(3):939-42. PubMed ID: 7471107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by amphotericin B in murine ependymoblastoma.
    Laurent G; Atassi G; Hildebrand J
    Cancer Res; 1976 Nov; 36(11 Pt 1):4069-73. PubMed ID: 975049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) toxicity by acetohydroxamic acid analogues of 3-nitropyrazole in vitro.
    Mulcahy RT; Wustrow DJ; Hark RR; Kende AS
    Invest New Drugs; 1987; 5(3):281-7. PubMed ID: 3667163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low apparent risk of CCNU (lomustine)-associated clinical hepatotoxicity in cats.
    Musser ML; Quinn HT; Chretin JD
    J Feline Med Surg; 2012 Dec; 14(12):871-5. PubMed ID: 22772480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of therapy on the antioxidant status in patients with melanoma.
    Gadjeva V; Dimov A; Georgieva N
    J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective monooxygenation of carcinostatic 1-(2-chloroethyl)-3-(cyclohexyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea by purified cytochrome P-450 isozymes.
    Potter DW; Levin W; Ryan DE; Thomas PE; Reed DJ
    Biochem Pharmacol; 1984 Feb; 33(4):609-13. PubMed ID: 6704177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolites of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea.
    Kohlhepp SJ; May HE; Reed DJ
    Drug Metab Dispos; 1981; 9(2):135-41. PubMed ID: 6113112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I evaluation of CCNU (lomustine) in tumor-bearing cats.
    Rassnick KM; Gieger TL; Williams LE; Ruslander DM; Northrup NC; Kristal O; Myers NC; Moore AS
    J Vet Intern Med; 2001; 15(3):196-9. PubMed ID: 11380027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various antineoplastic agents on an established human melanoma cell line (G-361).
    García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M
    Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.